These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2537608)

  • 1. Effect of dithranol treatment on arachidonic acid and its lipoxygenase products in psoriasis.
    Barr RM; Wong E; Cunningham FM; Mallet AI; Greaves MW
    Arch Dermatol Res; 1989; 280(8):474-6. PubMed ID: 2537608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoxygenase products of arachidonic acid in human inflamed skin.
    Black AK; Barr RM; Wong E; Brain S; Greaves MW; Dickinson R; Shroot B; Hensby CN
    Br J Clin Pharmacol; 1985 Sep; 20(3):185-90. PubMed ID: 2994700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Leukotrienes and monohydroxy fatty acids: controversial role in the pathogenesis of psoriasis].
    Ruzicka T
    Hautarzt; 1985 May; 36(5):255-8. PubMed ID: 2989218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical steroid treatment reduces arachidonic acid and leukotriene B4 in lesional skin of psoriasis.
    Wong E; Barr RM; Cunningham FM; Mistry K; Woollard PM; Mallet AI; Greaves MW
    Br J Clin Pharmacol; 1986 Dec; 22(6):627-32. PubMed ID: 3032226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic and clinical effects of lonapalene (RS 43179), a 5-lipoxygenase inhibitor, in psoriasis.
    Black AK; Camp RD; Mallet AI; Cunningham FM; Hofbauer M; Greaves MW
    J Invest Dermatol; 1990 Jul; 95(1):50-4. PubMed ID: 2164070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arachidonic acid in psoriasis. Pathogenic role and pharmacological regulation.
    Kragballe K; Voorhees JJ
    Acta Derm Venereol Suppl (Stockh); 1985; 120():12-7. PubMed ID: 3010612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukotrienes and other lipoxygenase products in the pathogenesis and therapy of psoriasis and other dermatoses.
    Voorhees JJ
    Arch Dermatol; 1983 Jul; 119(7):541-7. PubMed ID: 6305285
    [No Abstract]   [Full Text] [Related]  

  • 8. Cutaneous responses to lipoxygenase products of arachidonic acid.
    Dowd PM; Greaves MW
    Acta Derm Venereol Suppl (Stockh); 1985; 120():18-22. PubMed ID: 3010613
    [No Abstract]   [Full Text] [Related]  

  • 9. The analysis of arachidonic acid metabolites in normal, uninvolved and lesional psoriatic skin.
    Barr RM; Wong E; Mallet AI; Olins LA; Greaves MW
    Prostaglandins; 1984 Jul; 28(1):57-65. PubMed ID: 6435188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of etretinate on the cyclo-oxygenase and lipoxygenase products of arachidonic acid metabolism in psoriatic skin.
    Wong E; Barr RM; Brain SD; Greaves MW; Olins LA; Mallet AI
    Br J Clin Pharmacol; 1984 Oct; 18(4):523-7. PubMed ID: 6091710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of endotoxin on the synthesis of lipoxygenase products formed from arachidonic acid by rat alveolar macrophages].
    Lehmann B; Kämpf A; Scheuch DW
    Biomed Biochim Acta; 1990; 49(5):375-83. PubMed ID: 2176784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosynthesis of lipoxygenase products by enzyme preparations from normal and psoriatic skin.
    Ziboh VA; Casebolt TL; Marcelo CL; Voorhees JJ
    J Invest Dermatol; 1984 Dec; 83(6):426-30. PubMed ID: 6094672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-performance liquid chromatographic quantitation of cyclooxygenase and lipoxygenase metabolites of arachidonic acid from rat polymorphonuclear leukocytes.
    Tordjman C; Serkiz B; Rambaud F; Bonnet J; Volland JP
    J Chromatogr; 1990 Oct; 532(1):135-43. PubMed ID: 1964162
    [No Abstract]   [Full Text] [Related]  

  • 14. Anthralin (1,8-dihydroxyanthrone) is a potent inhibitor of leukotriene production and LTB4-omega oxidation by human neutrophils.
    Schröder JM
    J Invest Dermatol; 1986 Nov; 87(5):624-9. PubMed ID: 3021863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro synthesis of 12-hydroxy-eicosatetraenoic acid is increased in uninvolved psoriatic epidermis.
    Kragballe K; Desjarlais L; Duell EA; Voorhees JJ
    J Invest Dermatol; 1986 Jul; 87(1):47-52. PubMed ID: 3088130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of lipoxygenase products in the avascular tissues of the eye.
    Williams RN; Delamere NA; Paterson CA
    Exp Eye Res; 1985 Dec; 41(6):733-8. PubMed ID: 3007188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of eicosanoid formation by lesional skin of psoriasis: an ex vivo skin model.
    Fogh K; Iversen L; Herlin T; Kragballe K
    Acta Derm Venereol; 1993 Jun; 73(3):191-3. PubMed ID: 8105616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneous distribution of lipoxygenase products in psoriatic skin lesions.
    Fogh K; Kiil J; Herlin T; Ternowitz T; Kragballe K
    Arch Dermatol Res; 1987; 279(8):504-11. PubMed ID: 2829753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphonuclear leukocyte 5-lipoxygenase activity in psoriasis.
    Ruzicka T; Radspieler H; Strasser T; Przybilla B; Ring J
    Prostaglandins Leukot Med; 1985 Jun; 18(3):313-9. PubMed ID: 2991947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of chemotactic lipoxygenase products of arachidonate metabolism in psoriatic skin.
    Grabbe J; Czarnetzki BM; Rosenbach T; Mardin M
    J Invest Dermatol; 1984 May; 82(5):477-9. PubMed ID: 6096449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.